Sun Pharmaceutical Industries Share Price Today - Live Blog for May 05, 2025

Sun Pharmaceutical Industries Ltd stock price decreased by -0.03%, with the current market value at ₹1,835.00 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

The share price of Sun Pharmaceutical Industries Ltd experienced a -0.23% slump and is currently trading at ₹1,835.90. While the stock maintains a PE ratio of 38.3800, the industry PE is 34.3056, raising questions about valuation.

Sun Pharmaceutical Industries Ltd's shares experienced a 0.05% uptick, and they are currently valued at ₹1,841.70, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.0372 and an ROE of 15.9938%.

Sun Pharmaceutical Industries Ltd's shares saw an increase of 0.08%, reaching the current market price of ₹1,841.50. This development underscores the stock's growing popularity.

The share price of Sun Pharmaceutical Industries Ltd soared by an impressive 0.07%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,840.05 per share.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.07% decline, and it currently trades at ₹1,838.80 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

There was no alteration in the share price of Sun Pharmaceutical Industries Ltd, and it is currently trading at ₹1,840.00. This lack of change could lead investors to revisit their investment strategies and consider the stock's valuation.

Sun Pharmaceutical Industries Ltd's stock has risen by a substantial 0.06%, and as of now, it's trading at ₹1,840.05 per share. This upward trajectory is attracting keen interest from investors.

Sun Pharmaceutical Industries Ltd witnessed a notable 0.05% surge in its share price and is presently trading at ₹1,839.00, captivating the attention of market participants.

In the financial arena, Sun Pharmaceutical Industries Ltd's stock price has increased by 0.03%, with its current market value per share resting at ₹1,838.15. This development highlights the stock's appeal to investors.

In the financial arena, Sun Pharmaceutical Industries Ltd's stock price has increased by 0.13%, with its current market value per share resting at ₹1,837.55. This development highlights the stock's appeal to investors.

Sun Pharmaceutical Industries Ltd stock price decreased by -0.13%, with the current market value at ₹1,835.10 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Sun Pharmaceutical Industries Ltd observed a -0.02% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,837.40. The stock has a PE ratio of 38.3800, an ROE of 15.9938% and a debt to equity ratio of 0.0372.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.08%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,837.85, and market participants are assessing the implications. The stock has a PE ratio of 38.3800, an ROE of 15.9938% and a debt to equity ratio of 0.0372.

Following a noteworthy 0.13% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,839.30. When it comes to valuation, this stock has a PE ratio of 38.3800, with the industry PE ratio at 34.3056.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.14%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,837.00, and market participants are assessing the implications. The stock has a PE ratio of 38.3800, an ROE of 15.9938% and a debt to equity ratio of 0.0372.

In recent times, Sun Pharmaceutical Industries Ltd witnessed a decline of -0.12% in its share price, and it currently trades at ₹1,839.55 per share. The stock has an ROE of 15.9938% and debt to equity ratio of 0.0372.

In a noteworthy development, Sun Pharmaceutical Industries Ltd witnessed a remarkable 0.10% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,841.80 per share. The stock has an ROE of 15.9938% and debt to equity ratio of 0.0372.

The stock of Sun Pharmaceutical Industries Ltd is on the rise, registering an impressive 0.10% increase and currently trading at ₹1,838.00 per share. Investors are taking notice of this upward momentum.

The stock price of Sun Pharmaceutical Industries Ltd enjoyed a significant 0.37% boost, with the current market value at ₹1,836.35 per share. This surge has not gone unnoticed by investors.

With a -0.04% decrease, Sun Pharmaceutical Industries Ltd's share price is now at ₹1,831.30. The stock is currently trading at a PE of 38.3800, while the industry PE is 34.3056, prompting investors to assess its value proposition.

Increased investor interest has propelled Sun Pharmaceutical Industries Ltd's stock to a significant 0.43% gain, with the share price now at ₹1,835.35. Notably, the stock's PE ratio stands at 38.3800, and its Return on Equity (ROE) is 15.9938%.

Sun Pharmaceutical Industries Ltd displayed price stability, with no changes, and is trading at ₹1,826.00. This sustained performance invites investors to assess whether the stock aligns with their long-term investment goals.

Increased investor interest has propelled Sun Pharmaceutical Industries Ltd's stock to a significant 0.09% gain, with the share price now at ₹1,825.10. Notably, the stock's PE ratio stands at 38.3800, and its Return on Equity (ROE) is 15.9938%.

Increased investor interest has propelled Sun Pharmaceutical Industries Ltd's stock to a significant 2.32% gain, with the share price now at ₹1,828.00. Notably, the stock's PE ratio stands at 38.3800, and its Return on Equity (ROE) is 15.9938%.

Sun Pharmaceutical Industries Ltd's shares experienced a 2.32% uptick, and they are currently valued at ₹1,828.00, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.0372 and an ROE of 15.9938%.